๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The cholinergic system, sigma-1 receptors and cognition

โœ Scribed by Aren van Waarde; Nisha K. Ramakrishnan; Anna A. Rybczynska; Philip H. Elsinga; Kiichi Ishiwata; Ingrid M. Nijholt; Paul G.M. Luiten; Rudi A. Dierckx

Book ID
116285716
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
531 KB
Volume
221
Category
Article
ISSN
0166-4328

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

CENTRAL CHOLINERGIC SYSTEMS AND COGNITIO
CENTRAL CHOLINERGIC SYSTEMS AND COGNITION
โœ Everitt, Barry J.; Robbins, Trevor W. ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› Annual Reviews ๐ŸŒ English โš– 953 KB
The pharmacology of sigma-1 receptors
The pharmacology of sigma-1 receptors
โœ Tangui Maurice; Tsung-Ping Su ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 288 KB
Cognition and depression: the effects of
Cognition and depression: the effects of fluvoxamine, a sigma-1 receptor agonist, reconsidered
โœ Ian Hindmarch; Kenji Hashimoto ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 167 KB

## Abstract Cognitive impairment is a primary feature of patients with major depressive disorder (MDD) and is characterised by stressโ€induced neural atrophy. Via alphaโ€adrenergic, antiโ€cholinergic and antiโ€histaminic activities, several antidepressants can cause significant counterโ€therapeutic cogn